Emergent Biosolutions EBS Enterprise value

Enterprise value at other companies

Thermo Fisher ScientificTMO

$225.77B+21.7%

Regeneron PharmaceuticalsREGN

$65.61B+15.0%

SIGA TechnologiesSIGA

$143.93M-47.8%

AMP

Amphastar PharmaceuticalsAMPH

$1.35B-16.7%

Amneal Pharmaceuticals, Inc.AMRX

$7.97B+71.3%

Lifecore Biomedical, Inc.LFCR

$155.49M—

FAQ

What is Emergent Biosolutions's enterprise value?

Emergent Biosolutions (EBS) reported enterprise value of $879.68M in Q2 2026.

How has Emergent Biosolutions's enterprise value changed year-over-year?

Emergent Biosolutions's enterprise value increased by 13.9% year-over-year, from $772.56M to $879.68M.

What is the long-term trend for Emergent Biosolutions's enterprise value?

Over 5 years (2020 to 2025), Emergent Biosolutions's enterprise value has grown at a -27.5% compound annual growth rate (CAGR), from $5.11B to $1.02B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.